Kalexsyn provides new tool to its scientists

Companies that do research for other pharmaceutical companies--contract research organizations--are among the innovators that are making a name for themselves in Southwest Michigan. 
One of those, Kalexsyn, recently announced every chemist on its staff will have access to SciFinder, which combines databases with advanced search and analysis technologies. It provides researchers with chemical information that is publicly disclosed, high quality, and from a reliable source.
Kalexsyn has entered into a three-year agreement with Chemical Abstracts Services, the maker of SciFinder to receive access to the service.
Chemical Abstracts Services says 47 of the top 50 pharmaceutical and biotechnology companies, and 46 of the top 50 chemical organizations around the world rely on SciFinder to save time and money by learning from previously disclosed research that is collected, organized and made discoverable by CAS.
The company says a team of scientists worldwide curates and controls the quality of the Chemical Abstracts Services databases, which it says are recognized as the most comprehensive and authoritative by chemical and pharmaceutical companies, universities, government organizations and patent offices around the world.
"There's no other service that offers what SciFinder brings to the lab," says Dr. Robert Gadwood, president and chief scientific officer at Kalexsyn.

Founded in 2003, Kalexsyn's scientists on average have 15 years each of experience in medicinal chemistry needed in drug development research. The company offers clients both tailored short- and long-term contract arrangements.  

Writer: Kathy Jennings, Second Wave Media
Source: Kalexsyn

Related Company